Erika Martinelli

University of Campania "Luigi Vanvitelli" — Italy

Medicine · Health Sciences

45h-index8.6kcitations275works7.32yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Colorectal Cancer Treatments and Studies(139), Lung Cancer Treatments and Mutations(74), Gastric Cancer Management and Outcomes(49), HER2/EGFR in Cancer Research(35), Cancer Genomics and Diagnostics(30)

Publications274 total

CO259 Use of Encorafenib + Cetuximab EC in Patients With BRAF V600E–Mutant Metastatic Colorectal Cancer (mCRC) in Real-World Settings: Data Visualization From a Pooled Dataset of European Observational Studies
Value in Health·2025
Efficacy and safety of atezolizumab plus bevacizumab in MSI-like metastatic colorectal cancer: a multicenter, single-arm, phase II, open-label clinical trial
ESMO Open·2025Open Access
Genomic profiling of high tumor mutational load in microsatellite-stable colorectal cancer uncovers MAPK signaling pathway alterations following anti-EGFR therapy
ESMO Open·2025Open Access
Conversion Ability of Immunotherapy in Hepatocellular Carcinoma: Insights from the International Converse Study
Liver Cancer·2025· 2 citedOpen Access
158P Atezolizumab plus bevacizumab as first-line therapy in unresectable HCC: Final analysis from phase IIIb AMETHISTA study
Annals of Oncology·2025Open Access
202P Investigating molecular pathways of acquired resistance to lenvatinib in hepatocellular carcinoma: From cellular models to patient-derived samples
Annals of Oncology·2025Open Access
First-line immunotherapy combination in squamous cell anal carcinoma: hope in a neglected disease
The Lancet·2025· 1 cited
“Aging and epigenetic implications in radiotherapy: The promise of BNCT”
Ageing Research Reviews·2025· 4 citedOpen Access
OS-064 Integrating gut microbiota composition and machine learning to predict therapeutic response in hepatocellular carcinoma treated with Atezolizumab and Bevacizumab: exploratory analysis from the phase 3b AMETHISTA study
Journal of Hepatology·2025· 1 cited
Atezolizumab plus bevacizumab as first-line treatment of unresectable hepatocellular carcinoma: interim analysis results from the phase IIIb AMETHISTA trial
ESMO Open·2025· 14 citedOpen Access
Correction: Regorafenib in combination with silybin as a novel potential strategy for the treatment of metastatic colorectal cancer
Oncotarget·2025Open Access
81P Evaluating the effect of lenvatinib-resistance in hepatocellular carcinoma cells and in lenvatinib-resistant patient-derived PBMCs
ESMO Open·2024Open Access
A phase II open‐label study with atezolizumab (atezo) in combination with bevacizumab (bev) in patients (pts) with advanced chemotherapy-resistant colorectal cancer (CRC) and MSI‐like molecular signature: The MoTriColor Consortium CT3 study.
Journal of Clinical Oncology·2024· 2 cited
Prevention of cardiovascular complications in elderly cancer patients
Vascular Pharmacology·2024
Targeting the EGFR signalling pathway in metastatic colorectal cancer
˜The œLancet. Gastroenterology & hepatology·2024· 55 cited
Anti-EGFR Rechallenge in Patients With Refractory ctDNA <i>RAS/BRAF</i> wt Metastatic Colorectal Cancer
JAMA Network Open·2024· 37 citedOpen Access
614P Effect of KRASG12 mutations on overall survival in patients with refractory metastatic colorectal cancer: A post-hoc analysis of the phase III SUNLIGHT trial
Annals of Oncology·2023· 2 cited
124P Clinicopathological nomogram for predicting fibroblast growth factor receptor 2 (FGFR2) gene fusion/rearrangement (F/R) in intrahepatic cholangiocarcinoma (iCCA)
Annals of Oncology·2023· 1 citedOpen Access
559MO Rechallenge with EGFR inhibitors in ctDNA RAS/BRAF wild type refractory metastatic colorectal cancer: Individual patients’ data pooled analysis from 4 phase II trials
Annals of Oncology·2023· 3 citedOpen Access
Evaluation of exercise capacity by means of cardiopulmonary exercise testing (CPET) in older adult cancer patients undergoing antineoplastic treatments
Journal of Gerontology and Geriatrics·2023Open Access
page 1 of 14Next →

Frequent Co-authors

Fortunato Ciardiello(35), Teresa Troiani(30), Floriana Morgillo(26), Stefania Napolitano(12), Giulia Martini(11), Ferdinando De Vita(11), Carminia Maria Della Corte(10), Claudia Cardone(9), Donata Vitagliano(9), Michele Orditura(9), Davide Ciardiello(8), Evaristo Maiello(8), Josep Tabernero(7), Nicola Normanno(7), Liberato Berrino(7), Andrés Cervantes(6), Anna Maria Rachiglio(6), Raffaele De Palma(6), Anna Nappi(5), Matilde Lambiase(5)